Prostate cancer diagnosis using blood exosomes
Part of Cancer, Kidney & urinary clinical trials.
This study explores whether a simple blood test that looks at tiny particles called exosomes can help diagnose prostate cancer, possibly reducing the need for biopsies. If you have higher PSA levels and are scheduled for a biopsy, this trial might be a fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your blood PSA (prostate-specific antigen) level is higher than 4 ng/dL.
- You have symptoms or test results that suggest prostate cancer may be present.
- You are willing to have a prostate biopsy.
- You have not been diagnosed with prostate cancer before.
- You have not had any other type of cancer in the last two years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This study looks at whether a blood test that finds tiny amounts of remaining cancer (called minimal residual disease) can help predict how well treatment works for men with prostate cancer that has spread. If you qualify, you'll help researchers understand if this test can guide future treatment decisions.
This study is checking how well a blood test (liquid biopsy) can find prostate cancer and compare it to a special PET scan (PSMA-PET). If you qualify, you might help improve how we track prostate cancer without needing more invasive biopsies.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.